Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Non Small Cell Lung Cancer|Metastatic Breast Cancer
Interventions: DRUG: Pazopanib|DRUG: Vinorelbine
Sponsor: Northwestern University
Collaborators: Robert H. Lurie Cancer Center